CANTA, ANNALISA ROSANNA
 Distribuzione geografica
Continente #
NA - Nord America 19.778
AS - Asia 13.862
EU - Europa 9.874
SA - Sud America 1.617
AF - Africa 309
OC - Oceania 81
Continente sconosciuto - Info sul continente non disponibili 26
Totale 45.547
Nazione #
US - Stati Uniti d'America 18.669
SG - Singapore 4.629
CN - Cina 2.809
VN - Vietnam 2.683
IT - Italia 2.404
DE - Germania 1.566
HK - Hong Kong 1.463
RU - Federazione Russa 1.292
BR - Brasile 1.205
SE - Svezia 1.067
CA - Canada 938
IE - Irlanda 834
GB - Regno Unito 559
UA - Ucraina 555
FR - Francia 449
IN - India 449
KR - Corea 336
FI - Finlandia 266
BD - Bangladesh 252
ID - Indonesia 203
JP - Giappone 171
AR - Argentina 158
AT - Austria 155
TR - Turchia 146
NL - Olanda 131
IQ - Iraq 126
ZA - Sudafrica 104
MX - Messico 103
ES - Italia 99
PK - Pakistan 96
PL - Polonia 87
DK - Danimarca 80
LT - Lituania 80
CH - Svizzera 64
SA - Arabia Saudita 62
AU - Australia 60
BE - Belgio 55
EC - Ecuador 55
PH - Filippine 55
CO - Colombia 49
IR - Iran 48
VE - Venezuela 48
MY - Malesia 43
EG - Egitto 39
CL - Cile 33
UZ - Uzbekistan 32
AE - Emirati Arabi Uniti 29
PY - Paraguay 29
TW - Taiwan 29
MA - Marocco 27
RO - Romania 26
TN - Tunisia 26
KZ - Kazakistan 25
KE - Kenya 24
ET - Etiopia 23
IL - Israele 23
EU - Europa 20
TH - Thailandia 20
JO - Giordania 18
NZ - Nuova Zelanda 18
NP - Nepal 17
DZ - Algeria 14
OM - Oman 14
UY - Uruguay 14
AO - Angola 13
AZ - Azerbaigian 13
BO - Bolivia 13
CZ - Repubblica Ceca 13
PS - Palestinian Territory 12
BG - Bulgaria 11
PE - Perù 11
PT - Portogallo 11
CR - Costa Rica 10
HN - Honduras 9
HR - Croazia 9
HU - Ungheria 9
JM - Giamaica 9
KG - Kirghizistan 9
LB - Libano 9
AL - Albania 8
BH - Bahrain 8
NI - Nicaragua 8
MD - Moldavia 7
NG - Nigeria 7
NO - Norvegia 7
PA - Panama 7
RS - Serbia 7
GR - Grecia 6
KW - Kuwait 6
SN - Senegal 6
CI - Costa d'Avorio 5
DO - Repubblica Dominicana 5
SK - Slovacchia (Repubblica Slovacca) 5
LV - Lettonia 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
BB - Barbados 3
BN - Brunei Darussalam 3
BY - Bielorussia 3
GE - Georgia 3
Totale 45.480
Città #
Singapore 2.882
Ann Arbor 2.460
Ashburn 1.646
Dallas 1.509
Hong Kong 1.404
San Jose 1.355
Milan 942
Woodbridge 854
Dublin 814
Ho Chi Minh City 803
Chandler 791
Frankfurt am Main 773
Toronto 655
Houston 654
Hanoi 635
Wilmington 552
Jacksonville 543
New York 527
Fairfield 480
Dearborn 436
Los Angeles 430
Santa Clara 421
Beijing 417
Boardman 300
Chicago 296
Princeton 282
Hefei 273
Seoul 254
Council Bluffs 252
Seattle 230
The Dalles 226
Nanjing 190
Shanghai 174
Rome 173
Lauterbourg 161
Buffalo 158
Cambridge 142
Jakarta 139
Vienna 136
Helsinki 119
São Paulo 114
Guangzhou 109
Moscow 106
Orem 106
Columbus 93
Munich 91
Da Nang 89
Lachine 84
Lawrence 83
Tokyo 82
Dong Ket 77
Haiphong 76
Altamura 74
Chennai 69
Denver 63
Nanchang 60
Shenyang 60
London 59
Montreal 59
Vilnius 57
Baghdad 53
Phoenix 53
Atlanta 52
Ha Long 52
Hải Dương 52
Pune 52
Brooklyn 50
Warsaw 50
Andover 49
Carate Brianza 49
Nuremberg 48
Amsterdam 47
Biên Hòa 46
Zurich 46
Grafing 45
Johannesburg 45
Can Tho 43
Changsha 43
Stockholm 43
Falls Church 42
San Diego 42
Jinan 41
Fremont 40
Basingstoke 38
Bắc Ninh 38
Zhengzhou 38
Brussels 37
Rio de Janeiro 37
San Francisco 37
Tianjin 37
Jiaxing 35
Ninh Bình 35
Nürnberg 35
Poplar 35
Dhaka 34
Hangzhou 34
Kunming 32
Manchester 32
Mexico City 32
Vũng Tàu 32
Totale 28.780
Nome #
CIPN and its mechanism of development 634
ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier 607
Paclitaxel alters the microvascular network in the central and peripheral nervous system of rats with chemotherapy-induced painful peripheral neuropathy 581
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: the role of nerve excitability testing 509
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 504
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 465
Effect of age on metabolomic changes in a model of paclitaxel‐induced peripheral neurotoxicity 453
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 434
Angiogenesis-Related New Mechanisms for Chemotherapy-Induced Painful Peripheral Neuropathy in the Rat 424
Age-related changes in the function and structure of the peripheral sensory pathway in mice 424
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 414
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 412
Enhanced brain targeting of engineered solid lipid nanoparticles 406
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 402
Effect of age on metabolomic changes in a model of paclitaxel-induced neurotoxicity 401
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 395
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 387
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 383
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis 369
Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats 366
Investigation of Supraspinal Plasticity in a Rat Model of Painful Paclitaxel-induced Peripheral Neuropathy 364
ITF6475, a New Histone Deacetylase 6 Inhibitor, Prevents Painful Neuropathy Induced by Paclitaxel 363
CENTRAL AND PERIPHERAL MICROVASCULAR NETWORK IS ABNORMAL IN RATS WITH PAINFUL-CHEMOTHERAPY INDUCED NEUROPATHY: NEW PATHOPHYSIOLOGICAL MECHANISMS OVER THE HORIZON? 363
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 359
Sox2 deficiency causes neurodegeneration and impaired neurogenesis in the adult mouse brain 341
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 339
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation 334
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 330
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 327
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 325
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 324
Bortezomid-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat. 319
Translation of paclitaxel-induced peripheral neurotoxicity from mice to patients: the importance of model selection 318
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 317
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 314
Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats 313
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 313
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 309
Effects of Islet Transplantation and Mesenchymal Stem Cell Co-Transplantation in the Protection of Diabetic Neuropathy in Streptozotocin-Induced Diabetic Rats 308
Insight Into Chemotherapeutic-Agents-Induced-Neuroinflammation In Rat Experimental Neuropathies 307
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 306
Dorsal Root Ganglia Neurons Morphometry Analysing Method Optimization 305
EVALUATION OF SATELLITE GLIAL CELLS CHANGES IN DORSAL ROOT GANGLIA IN CHEMOTHERAPY-INDUCED NEUROTOXICITY MODELS 304
Bortezomib-Induced Peripheral Neurotoxicity: a Preclinical Model to Study Neuropathic Pain in Rat 304
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy 300
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 299
Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity 297
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™) 297
OCT2 transporter involvement in development of cisplatin toxicity 296
Cisplatin-induced peripheral neuropathy: neuroprotection by erythropoietin without affecting tumour growth 295
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 295
Intraepidermal nerve fiber density in rat foot pad: Neuropathologic- neurophysiologic correlation 294
Topiramate possible double efficacy profile: Oxaliplatin-induced peripheral neurotoxicity prevention and anticancer synergic action 294
Expression and distribution of 'high affinity' glutamate transporters GLT1, GLAST, EAAC1 and of GCPII in the rat peripheral nervous system 292
Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model 291
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells 286
Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity 286
In vivo study of Carfilzomib-Induced Neuropathy 286
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 283
The ventral caudal nerve: a physiologic-morphometric study in three different rat strains 282
NCX2 modulation to prevent axonal damage related to Oxaliplatin-induced peripheral neurotoxicity 280
Enhanced brain targeting of engineered solid lipid nanoparticles 279
Tubulin: a target for antineoplastic drugs into the cancer cells but also in the peripheral nervous system 278
Morphological and functional study of the caudal nerve in a rat model of peripheral neuropathy 277
Effects of different erythropoietin schedules in cisplatin-induced peripheral neurotoxicity 277
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 276
Satellite Glial Cells in Chemotherapy Induced Peripheral Neuropathy 275
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 274
Morphological and functional assessment of NCX2 potential role in axonal damage related to Oxaliplatin 272
Effect of proteasome inhibition on the central and peripheral nervous system 272
Oxaliplatin induced peripheral neurotoxicity (OIPN) and ion unbalance: the perilous link between acute and chronic neurotoxicity. 271
Multimodal experimental approach to the study of human neurological diseases 268
MORPHOLOGICAL AND METABOLOMIC CHANGES IN PIPN 266
NEUROINFLAMMATION AS A POTENTIAL TARGET FOR CIPN DIAGNOSTIC AND TREATMENT 264
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 264
A new animal model of chemotherapy induced peripheral neurotoxicity : the immunodeficient mouse 261
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 260
Characterization in vivo of two different molecular mechanisms involved in the development of bortezomib-induced peripheral neuropathy 260
Bortezomib-induced peripheral neurotoxicity: A neurophysiological study in a rat model 259
Cr4056: a novel potent anti-nociceptive agent for several animal models of neuropathic pain 259
Central and peripheral neoangiogenesis in paclitaxel-induced painful peripheral neuropathy 258
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy 257
ANALGELSIC EFFECT OF BUPRENORPHINE IN AN EXPERIMENTAL MODEL OF PAINFUL DIABETIC PERIPHERAL NEUROPATHY 255
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies 254
Studying the caudal nerve anatomy and physiology to refine detection of peripheral nerve damage in rodent models. 254
A large-field polarisation-resolved laser scanning microscope: Applications to CARS imaging 253
Characterization of bortezomib-induced peripheral neuropathy in an immune-suppressed murine model 252
Toward the identification of neuroprotective agents: G-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising SIGMA1 receptor agonist 252
BEHAVIOURAL AND MORPHOLOGICAL DESCRIPTION OF BORTEZOMIB-INDUCED PAINFUL NEUROPATHY IN RATS 251
Transplanted pancreatic islets survive and reverse type I diabetic neuropathy 251
Platinum-taxane combination chemotherapy: Description of the first study to assess the general and peripheral neurotoxicity of their combined administration in the rat 250
Chemotherapy-induced allodinia: Neuroprotective effect of acetyl-L-carnitine 250
Neutrophil depletion during sensitization phase affects the chronic phase of Experimental Autoimmune Encephalomyelitis 250
Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity 249
Continuous Buprenorphine Delivery Effect in Streptozotocine-Induced Painful Diabetic Neuropathy in Rats 249
7T MRI first exploitation in a chemotherapy induced peripheral neurotoxicity in vivo model. 249
Experimental epothilone B neurotoxicity: Results of in vitro and in vivo studies 248
Genetic factors influencing the development of vincristine-induced neurotoxicity 248
Valproate protective effects on cisplatin-induced peripheral neuropathy: An in vitro and in vivo study 246
Paclitaxel: Chemotherapy and Neurotoxicity – The Two sides of the Coin 245
Totale 31.862
Categoria #
all - tutte 141.293
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 141.293


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.893 132 194 143 200 168 212 91 89 91 133 144 296
2022/20233.443 363 879 319 353 269 531 61 174 273 56 102 63
2023/20242.890 96 105 105 131 345 701 518 176 136 65 65 447
2024/20257.326 383 823 683 329 578 304 500 254 770 972 612 1.118
2025/202620.920 2.708 1.788 2.372 1.707 1.841 1.079 2.724 971 1.559 1.671 1.212 1.288
2026/2027115 115 0 0 0 0 0 0 0 0 0 0 0
Totale 46.710